We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+10.55%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$3.14B
AUM Growth
+$728M
Cap. Flow
+$534M
Cap. Flow %
17.01%
Top 10 Hldgs %
37.86%
Holding
6,828
New
511
Increased
3,030
Reduced
2,253
Closed
625

Sector Composition

Rank Sector Weight
1 Technology 21.21%
2 Consumer Discretionary 7.37%
3 Financials 6.36%
4 Healthcare 5.92%
5 Industrials 5.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KD icon
1426
Kyndryl
KD
$3.04B
$179K 0.01%
12,154
+2,497
+26% +$35.4K
KOS icon
1427
Kosmos Energy
KOS
$1.51B
$179K 0.01%
24,134
+21,679
+883% +$159K
PLOW icon
1428
Douglas Dynamics
PLOW
$976M
$179K 0.01%
5,620
+1,597
+40% +$58.8K
RLX icon
1429
RLX Technology
RLX
$2.46B
$179K 0.01%
61,804
+42,081
+213% +$102K
HLI icon
1430
Houlihan Lokey
HLI
$8.72B
$178K 0.01%
2,034
+1,829
+892% +$172K
LINC icon
1431
Lincoln Educational Services
LINC
$965M
$178K 0.01%
31,473
+30,075
+2,151% +$183K
VC icon
1432
Visteon
VC
$2.83B
$178K 0.01%
1,135
+45
+4% +$6.96K
DGII icon
1433
Digi International
DGII
$3.16B
$177K 0.01%
5,268
+5,079
+2,687% +$174K
GGB icon
1434
Gerdau
GGB
$9.36B
$177K 0.01%
43,084
+21,753
+102% +$97.4K
TMP icon
1435
Tompkins Financial
TMP
$1.41B
$177K 0.01%
2,675
-495
-16% -$36.4K
GHC icon
1436
Graham Holdings Company
GHC
$4.99B
$176K 0.01%
296
+23
+8% +$14.3K
MP icon
1437
MP Materials
MP
$9.76B
$176K 0.01%
6,245
+167
+3% +$5.05K
PAGS icon
1438
PagSeguro Digital
PAGS
$2.5B
$176K 0.01%
20,522
+10,816
+111% +$96.7K
SEF icon
1439
ProShares Short Financials
SEF
$13M
$176K 0.01%
3,305
-4,328
-57% -$219K
THO icon
1440
Thor Industries
THO
$4.2B
$176K 0.01%
2,212
+1,165
+111% +$103K
FFIV icon
1441
F5
FFIV
$23.5B
$175K 0.01%
1,197
-813
-40% -$117K
HOOD icon
1442
Robinhood
HOOD
$84.5B
$175K 0.01%
18,088
-19,422
-52% -$185K
HRMY icon
1443
Harmony Biosciences
HRMY
$2.27B
$175K 0.01%
5,367
+5,098
+1,895% +$232K
RIVN icon
1444
Rivian
RIVN
$23.7B
$175K 0.01%
11,302
+6,288
+125% +$106K
G icon
1445
Genpact
G
$5.72B
$174K 0.01%
3,755
+386
+11% +$18K
TYL icon
1446
Tyler Technologies
TYL
$13.2B
$174K 0.01%
492
-1,276
-72% -$415K
ZYME icon
1447
Zymeworks
ZYME
$1.74B
$174K 0.01%
19,275
+15,999
+488% +$140K
BEAM icon
1448
Beam Therapeutics
BEAM
$2.77B
$173K 0.01%
5,660
+4,090
+261% +$161K
COKE icon
1449
Coca-Cola Consolidated
COKE
$12.1B
$173K 0.01%
3,240
+2,420
+295% +$125K
INOD icon
1450
Innodata
INOD
$2.04B
$173K 0.01%
20,256
-1,815
-8% -$10.3K

Similar funds

Tower Research Capital (TRC)'s Q1 2023 Portfolio in Review

As of Q1 2023, Tower Research Capital (TRC) held 6,828 positions worth $3.14B, up 30% from $2.41B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Tower Research Capital (TRC) deployed $534M of net new capital in Q1 2023, opening 511 new positions and adding to 3,030 existing holdings. Its largest new stake was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $52.8M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2023 buy was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q1 2023, an estimated $204M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2023 reduction was iShares Russell 2000 ETF, cutting an estimated $52.8M.
  • Tower Research Capital (TRC) fully exited Myovant Sciences Ltd. in Q1 2023, selling an estimated $7.26M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 38% of its $3.14B portfolio in Q1 2023.
  • Tower Research Capital (TRC) opened 511 new positions and closed 625 in Q1 2023.
  • Tower Research Capital (TRC)'s portfolio value rose 30% quarter-over-quarter to $3.14B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2023, filed 9 May 2023.